{"count": 5, "results": [{"_id": "16443892", "pmid": 16443892, "title": "Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program.", "journal": "Diabetes Care", "authors": ["Brown JS", "Wing R", "Barrett-Connor E", "Nyberg LM", "Kusek JW", "Orchard TJ", "Ma Y", "Vittinghoff E", "Kanaya AM", "Diabetes Prevention Program Research Group"], "date": "2006-02-01T00:00:00Z", "doi": "10.2337/diacare.29.02.06.dc05-1781", "meta_date_publication": "2006 Feb", "meta_volume": "29", "meta_issue": "2", "meta_pages": "385-90", "score": 50061.176, "text_hl": "RESULTS: The prevalence of total (stress or urge) weekly @<m>DISEASE_Urinary_Incontinence</m> @DISEASE_MESH:D014549 @@@incontinence@@@ was lower among @SPECIES_9606 @@@women@@@ in the intensive lifestyle group (38.3%) than those randomized to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (48.1%) or placebo (45.7%). ", "citations": {"NLM": "Brown JS, Wing R, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, Ma Y, Vittinghoff E, Kanaya AM, Diabetes Prevention Program Research Group. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care. 2006 Feb;29(2):385-90. PMID: 16443892", "BibTeX": "@article{16443892, title={Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program.}, author={Brown JS and Wing R and Barrett-Connor E and Nyberg LM and Kusek JW and Orchard TJ and Ma Y and Vittinghoff E and Kanaya AM and Diabetes Prevention Program Research Group}, journal={Diabetes Care}, volume={29}, number={2}, pages={385-90}}"}}, {"_id": "6336343", "pmid": 6336343, "title": "Diarrhea and metformin in a diabetic clinic.", "journal": "Diabetes Care", "authors": ["Dandona P", "Fonseca V", "Mier A", "Beckett AG"], "date": "1983-09-01T00:00:00Z", "doi": "10.2337/diacare.6.5.472", "meta_date_publication": "1983 Sep-Oct", "meta_volume": "6", "meta_issue": "5", "meta_pages": "472-4", "score": 50060.73, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is by far the commonest cause of @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ and @<m>DISEASE_Urinary_Incontinence</m> @DISEASE_MESH:D014549 @@@incontinence@@@ in our @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ clinic, where it is used routinely. ", "citations": {"NLM": "Dandona P, Fonseca V, Mier A, Beckett AG. Diarrhea and metformin in a diabetic clinic. Diabetes Care. 1983 Sep-Oct;6(5):472-4. PMID: 6336343", "BibTeX": "@article{6336343, title={Diarrhea and metformin in a diabetic clinic.}, author={Dandona P and Fonseca V and Mier A and Beckett AG}, journal={Diabetes Care}, volume={6}, number={5}, pages={472-4}}"}}, {"_id": "11714216", "pmid": 11714216, "title": "Metformin as a cause of late-onset chronic diarrhea.", "journal": "Pharmacotherapy", "authors": ["Foss MT", "Clement KD"], "date": "2001-11-01T00:00:00Z", "doi": "10.1592/phco.21.17.1422.34430", "meta_date_publication": "2001 Nov", "meta_volume": "21", "meta_issue": "11", "meta_pages": "1422-4", "score": 50053.99, "text_hl": "Our @SPECIES_9606 @@@patient@@@ began to experience @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Colic @DISEASE_MESH:D003085 @@@abdominal cramping@@@, and explosive watery @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ that occasionally caused @<m>DISEASE_Urinary_Incontinence</m> @DISEASE_MESH:D014549 @@@incontinence@@@ after several years of stable @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy A trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ discontinuation resolved all @DISEASE_Signs_and_Symptoms_Digestive @DISEASE_MESH:D012817 @@@gastrointestinal symptoms@@@. ", "citations": {"NLM": "Foss MT, Clement KD. Metformin as a cause of late-onset chronic diarrhea. Pharmacotherapy. 2001 Nov;21(11):1422-4. PMID: 11714216", "BibTeX": "@article{11714216, title={Metformin as a cause of late-onset chronic diarrhea.}, author={Foss MT and Clement KD}, journal={Pharmacotherapy}, volume={21}, number={11}, pages={1422-4}}"}}, {"_id": "25352018", "pmid": 25352018, "title": "Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study.", "journal": "Int J Urol", "authors": ["Phelan S", "Kanaya AM", "Ma Y", "Vittinghoff E", "Barrett-Connor E", "Wing R", "Kusek JW", "Orchard TJ", "Crandall JP", "Montez MG", "Brown JS", "Diabetes Prevention Program Research Group"], "date": "2015-02-01T00:00:00Z", "doi": "10.1111/iju.12654", "meta_date_publication": "2015 Feb", "meta_volume": "22", "meta_issue": "2", "meta_pages": "206-12", "score": 50050.426, "text_hl": "RESULTS: At the study entry, the prevalence of weekly @<m>DISEASE_Urinary_Incontinence</m> @DISEASE_MESH:D014549 @@@urinary incontinence@@@ was lower in the intensive lifestyle intervention group compared with the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and placebo groups (44.2% vs 51.8%, 48.0% @<m>DISEASE_Urinary_Incontinence</m> @DISEASE_MESH:D014549 @@@urinary incontinence@@@/week, P = 0.04); during the 6-year follow-up period, these lower rates in intensive lifestyle intervention were maintained (46.7%, 53.1%, 49.9% @<m>DISEASE_Urinary_Incontinence</m> @DISEASE_MESH:D014549 @@@urinary incontinence@@@/week; P = 0.03). ", "citations": {"NLM": "Phelan S, Kanaya AM, Ma Y, Vittinghoff E, Barrett-Connor E, Wing R, Kusek JW, Orchard TJ, Crandall JP, Montez MG, Brown JS, Diabetes Prevention Program Research Group. Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study. Int J Urol. 2015 Feb;22(2):206-12. PMID: 25352018", "BibTeX": "@article{25352018, title={Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study.}, author={Phelan S and Kanaya AM and Ma Y and Vittinghoff E and Barrett-Connor E and Wing R and Kusek JW and Orchard TJ and Crandall JP and Montez MG and Brown JS and Diabetes Prevention Program Research Group}, journal={Int J Urol}, volume={22}, number={2}, pages={206-12}}"}}, {"_id": "11136287", "pmid": 11136287, "title": "Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.", "journal": "Aliment Pharmacol Ther", "authors": ["Bytzer P", "Talley NJ", "Jones MP", "Horowitz M"], "date": "2001-01-01T00:00:00Z", "doi": "10.1046/j.1365-2036.2001.00896.x", "meta_date_publication": "2001 Jan", "meta_volume": "15", "meta_issue": "1", "meta_pages": "137-42", "score": 50042.164, "text_hl": "RESULTS: 405 of the 956 @SPECIES_9606 @@@patients@@@ used oral hypoglycaemic drugs. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use was independently associated with chronic @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@ (odds ratio 3.08, 95% CI: 1.29-7.36, P < 0.02) and with @<m>DISEASE_Urinary_Incontinence</m> @DISEASE_MESH:D014549 @@@faecal incontinence@@@ (odds ratio 1.95, 95% CI: 1.10-3.47, P < 0.05). ", "citations": {"NLM": "Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001 Jan;15(1):137-42. PMID: 11136287", "BibTeX": "@article{11136287, title={Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.}, author={Bytzer P and Talley NJ and Jones MP and Horowitz M}, journal={Aliment Pharmacol Ther}, volume={15}, number={1}, pages={137-42}}"}}]}